BioCentury | Jul 26, 2001
Financial News

De Novo raises EUR27.3 million

...Quester; Cambridge Gateway; Incyte Genomics (INCY); and Roche (SWX:ROCZ). Returning investors included Avlar BioVentures; Prelude Cambridge Research and Innovation...
BioCentury | Apr 24, 2000
Finance

Old-fashioned values

...from the University of Cambridge's department of pharmacology. Investors include Prelude Trust, Avlar Bioventures and Cambridge Research and Innovation...
BioCentury | Mar 6, 2000
Finance

Best of both worlds

...formed Cambridge, U.K., company, will provide support services to the fund. Chris Keightley, director at Cambridge Research and Innovation...
Items per page:
1 - 3 of 3
BioCentury | Jul 26, 2001
Financial News

De Novo raises EUR27.3 million

...Quester; Cambridge Gateway; Incyte Genomics (INCY); and Roche (SWX:ROCZ). Returning investors included Avlar BioVentures; Prelude Cambridge Research and Innovation...
BioCentury | Apr 24, 2000
Finance

Old-fashioned values

...from the University of Cambridge's department of pharmacology. Investors include Prelude Trust, Avlar Bioventures and Cambridge Research and Innovation...
BioCentury | Mar 6, 2000
Finance

Best of both worlds

...formed Cambridge, U.K., company, will provide support services to the fund. Chris Keightley, director at Cambridge Research and Innovation...
Items per page:
1 - 3 of 3